293 related articles for article (PubMed ID: 18819824)
1. Hypocretin/orexin disturbances in neurological disorders.
Fronczek R; Baumann CR; Lammers GJ; Bassetti CL; Overeem S
Sleep Med Rev; 2009 Feb; 13(1):9-22. PubMed ID: 18819824
[TBL] [Abstract][Full Text] [Related]
2. [Hypocretin disturbance and sleep disorders].
Billiard M
Bull Acad Natl Med; 2011 Oct; 195(7):1567-78; discussion 1579-81. PubMed ID: 22812161
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
4. Roles of the hypocretin/orexins in the regulation of sleep and wakefulness.
Terao A; Haruyama T; Kimura K
Jpn J Vet Res; 2008 Jan; 55(2-3):75-83. PubMed ID: 18318109
[TBL] [Abstract][Full Text] [Related]
5. Roles of orexin/hypocretin in regulation of sleep/wakefulness and energy homeostasis.
Sakurai T
Sleep Med Rev; 2005 Aug; 9(4):231-41. PubMed ID: 15961331
[TBL] [Abstract][Full Text] [Related]
6. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter.
Baumann CR; Bassetti CL
Sleep Med Rev; 2005 Aug; 9(4):253-68. PubMed ID: 15979356
[TBL] [Abstract][Full Text] [Related]
7. The role of the hypothalamic neuropeptides hypocretin/orexin in the sleep-wake cycle.
Salin-Pascual RJ
Isr Med Assoc J; 2001 Feb; 3(2):144-6. PubMed ID: 11344826
[TBL] [Abstract][Full Text] [Related]
8. CSF hypocretin-1 levels are normal in patients with amyotrophic lateral sclerosis.
Van Rooij FG; Schelhaas HJ; Lammers GJ; Verbeek MM; Overeem S
Amyotroph Lateral Scler; 2009; 10(5-6):487-9. PubMed ID: 19922146
[TBL] [Abstract][Full Text] [Related]
9. Hypocretin/orexin, sleep and narcolepsy.
Hungs M; Mignot E
Bioessays; 2001 May; 23(5):397-408. PubMed ID: 11340621
[TBL] [Abstract][Full Text] [Related]
10. Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression.
Allard JS; Tizabi Y; Shaffery JP; Trouth CO; Manaye K
Neuropeptides; 2004 Oct; 38(5):311-5. PubMed ID: 15464197
[TBL] [Abstract][Full Text] [Related]
11. Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury.
Baumann CR; Stocker R; Imhof HG; Trentz O; Hersberger M; Mignot E; Bassetti CL
Neurology; 2005 Jul; 65(1):147-9. PubMed ID: 16009905
[TBL] [Abstract][Full Text] [Related]
12. Alertness and feeding behaviors in ADHD: does the hypocretin/orexin system play a role?
Cortese S; Konofal E; Lecendreux M
Med Hypotheses; 2008 Nov; 71(5):770-5. PubMed ID: 18678446
[TBL] [Abstract][Full Text] [Related]
13. Non-sleep effects of hypocretin/orexin.
Samson WK; Taylor MM; Ferguson AV
Sleep Med Rev; 2005 Aug; 9(4):243-52. PubMed ID: 16036174
[TBL] [Abstract][Full Text] [Related]
14. A mathematical model of homeostatic regulation of sleep-wake cycles by hypocretin/orexin.
Postnova S; Voigt K; Braun HA
J Biol Rhythms; 2009 Dec; 24(6):523-35. PubMed ID: 19926811
[TBL] [Abstract][Full Text] [Related]
15. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
Zeitzer JM; Nishino S; Mignot E
Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
[TBL] [Abstract][Full Text] [Related]
16. Hypocretin (orexin) loss in Parkinson's disease.
Fronczek R; Overeem S; Lee SY; Hegeman IM; van Pelt J; van Duinen SG; Lammers GJ; Swaab DF
Brain; 2007 Jun; 130(Pt 6):1577-85. PubMed ID: 17470494
[TBL] [Abstract][Full Text] [Related]
17. Narcolepsy in Parkinson's disease.
Haq IZ; Naidu Y; Reddy P; Chaudhuri KR
Expert Rev Neurother; 2010 Jun; 10(6):879-84. PubMed ID: 20518604
[TBL] [Abstract][Full Text] [Related]
18. The physiological role of orexins.
Martynska L; Wolinska-Witort E; Chmielowska M; Bik W; Baranowska B
Neuro Endocrinol Lett; 2005 Aug; 26(4):289-92. PubMed ID: 16135995
[TBL] [Abstract][Full Text] [Related]
19. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness.
Ohno K; Sakurai T
Front Neuroendocrinol; 2008 Jan; 29(1):70-87. PubMed ID: 17910982
[TBL] [Abstract][Full Text] [Related]
20. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.
Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K
J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
